ロード中...
High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer
BACKGROUND: Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer that is prone to recurrence and metastasis with worse prognosis. Epirubicin-based chemotherapy is of great importance for patients with TNBC, but resistance to epirubicin severely limits the application of t...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4500622/ https://ncbi.nlm.nih.gov/pubmed/26185453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S81214 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|